WHO 2021. Global tuberculosis report 2021, WHO.
Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-international union against tuberculosis and lung disease working group on anti-tuberculosis drug resistance surveillance. N Engl J Med. 2001;344(17):1294–303.
Article CAS PubMed Google Scholar
Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–67. https://doi.org/10.1111/jam.14478.
Article CAS PubMed Google Scholar
Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lonnroth K, et al. MDR tuberculosis—critical steps for prevention and control. N Engl J Med. 2010;363(11):1050–8.
Article CAS PubMed Google Scholar
Sulis G, Pai M. Isoniazid-resistant tuberculosis: a problem we can no longer ignore. PLoS Med. 2020;17(1): e1003023. https://doi.org/10.1371/journal.pmed.1003023.
Article PubMed PubMed Central Google Scholar
Chai J, Han X, Mei Q, Liu T, Walline JH, Xu J, et al. Clinical characteristics and mortality of non-tuberculous mycobacterial infection in immunocompromised vs. immunocompetent hosts. Front Med. 2022;9: 884446. https://doi.org/10.3389/fmed.2022.884446.
Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections—a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27(1):74. https://doi.org/10.1186/s12929-020-00667-6.
Article PubMed PubMed Central Google Scholar
Shamaei M, Mirsaeidi M. Nontuberculous mycobacteria, macrophages, and host innate immune response. Infect Immun. 2021;89(8): e0081220. https://doi.org/10.1128/IAI.00812-20.
Dahl VN, Molhave M, Floe A, van Ingen PJ, Schon PT, Lillebaek PT, et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis. 2022. https://doi.org/10.1016/j.ijid.2022.10.013.
Article PubMed PubMed Central Google Scholar
Tissot A, Thomas MF, Corris PA, Brodlie M. Nontuberculous mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice. BMC Pulm Med. 2018;18(1):86.
Article PubMed PubMed Central Google Scholar
Gill LI, Dominic C, Tiberi S. Atypical mycobacterial infections—management and when to treat. Curr Opin Pulm Med. 2021;27(3):216–23. https://doi.org/10.1097/MCP.0000000000000764.
Article CAS PubMed Google Scholar
Abate G, Stapleton JT, Rouphael N, Creech B, Stout JE, El Sahly HM, et al. Variability in the management of adults with pulmonary nontuberculous mycobacterial disease. Clin Infect Dis. 2021;72(7):1127–37.
Article CAS PubMed Google Scholar
Thornton CS, Mellett M, Jarand J, Barss L, Field SK, Fisher DA. The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health. Eur Respir Rev. 2021;30(160): 200299.
Article PubMed PubMed Central Google Scholar
Llibre A, Dedicoat M, Burel JG, Demangel C, O’Shea MK, Mauro C. Host immune-metabolic adaptations upon mycobacterial infections and associated co-morbidities. Front Immunol. 2021;12: 747387. https://doi.org/10.3389/fimmu.2021.747387.
Article CAS PubMed PubMed Central Google Scholar
Shi L, Jiang Q, Bushkin Y, Subbian S, Tyagi S. Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis infection. MBio. 2019;10(2):e02550-18.
Article PubMed PubMed Central Google Scholar
Paik S, Jo EK. An interplay between autophagy and immunometabolism for host defense against mycobacterial infection. Front Immunol. 2020;11: 603951. https://doi.org/10.3389/fimmu.2020.603951.
Article CAS PubMed PubMed Central Google Scholar
Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci USA. 2013;110(19):7820–5. https://doi.org/10.1073/pnas.1218599110.
Article PubMed PubMed Central Google Scholar
Kwai BXC, Collins AJ, Middleditch MJ, Sperry J, Bashiri G, Leung IKH. Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase. RSC Med Chem. 2021;12(1):57–61. https://doi.org/10.1039/d0md00301h.
Article CAS PubMed Google Scholar
Nair S, Huynh JP, Lampropoulou V, Loginicheva E, Esaulova E, Gounder AP, et al. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J Exp Med. 2018;215(4):1035–45. https://doi.org/10.1084/jem.20180118.
Article CAS PubMed PubMed Central Google Scholar
Gidon A, Louet C, Rost LM, Bruheim P, Flo TH. The tumor necrosis factor alpha and interleukin 6 auto-paracrine signaling loop controls Mycobacterium avium infection via induction of IRF1/IRG1 in human primary macrophages. MBio. 2021;12(5): e0212121. https://doi.org/10.1128/mBio.02121-21.
Zhao C, Jiang P, He Z, Yuan X, Guo J, Li Y, et al. Dimethyl itaconate protects against lippolysacchride-induced mastitis in mice by activating MAPKs and Nrf2 and inhibiting NF-kappaB signaling pathways. Microb Pathog. 2019;133: 103541. https://doi.org/10.1016/j.micpath.2019.05.024.
Article CAS PubMed Google Scholar
Kuo PC, Weng WT, Scofield BA, Paraiso HC, Brown DA, Wang PY, et al. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis. J Neuroinflamm. 2020;17(1):138.
Zhang S, Jiao Y, Li C, Liang X, Jia H, Nie Z, et al. Dimethyl itaconate alleviates the inflammatory responses of macrophages in sepsis. Inflammation. 2021;44(2):549–57. https://doi.org/10.1007/s10753-020-01352-4.
Article CAS PubMed Google Scholar
Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, et al. Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature. 2018;556(7702):501–4. https://doi.org/10.1038/s41586-018-0052-z.
Article CAS PubMed PubMed Central Google Scholar
Swain A, Bambouskova M, Kim H, Andhey PS, Duncan D, Auclair K, et al. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages. Nat Metab. 2020;2(7):594–602. https://doi.org/10.1038/s42255-020-0210-0.
Article CAS PubMed PubMed Central Google Scholar
ElAzzouny M, Tom CT, Evans CR, Olson LL, Tanga MJ, Gallagher KA, et al. Dimethyl itaconate is not metabolized into itaconate intracellularly. J Biol Chem. 2017;292(12):4766–9. https://doi.org/10.1074/jbc.C117.775270.
Article CAS PubMed PubMed Central Google Scholar
Yang CS, Kim JJ, Lee HM, Jin HS, Lee SH, Park JH, et al. The AMPK-PPARGC1A pathway is required for antimicrobial host defense through activation of autophagy. Autophagy. 2014;10(5):785–802. https://doi.org/10.4161/auto.28072.
Article CAS PubMed PubMed Central Google Scholar
Kim JK, Kim YS, Lee HM, Jin HS, Neupane C, Kim S, et al. GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat Commun. 2018;9(1):4184.
Article PubMed PubMed Central Google Scholar
Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Lin G, et al. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Wayne: Clinical and laboratory standards institute; 2011.
Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med. 2005;11(6):638–44. https://doi.org/10.1038/nm1252.
Article CAS PubMed PubMed Central Google Scholar
McKinney JD, HonerzuBentrup K, Munoz-Elias EJ, Miczak A, Chen B, Chan WT, et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature. 2000;406(6797):735–8. https://doi.org/10.1038/35021074.
Article CAS PubMed Google Scholar
Fahnoe KC, Flanagan ME, Gibson G, Shanmugasundaram V, Che Y, Tomaras AP. Non-traditional antibacterial screening approaches for the identification of novel inhibitors of the glyoxylate shunt in gram-negative pathogens. PLoS ONE. 2012;7(12): e51732. https://doi.org/10.1371/journal.pone.0051732.
Article CAS PubMed PubMed Central Google Scholar
Ahn S, Jung J, Jang IA, Madsen EL, Park W. Role of glyoxylate shunt in oxidative stress response. J Biol Chem. 2016;291(22):11928–38. https://doi.org/10.1074/jbc.M115.708149.
Article CAS PubMed PubMed Central Google Scholar
Ko EM, Kim JY, Lee S, Kim S, Hwang J, Oh JI. Regulation of the icl1 gene encoding the major isocitrate lyase in Mycobacterium smegmatis. J Bacteriol. 2021;203(23): e0040221. https://doi.org/10.1128/JB.00402-21.
Van Dis E, Fox DM, Morrison HM, Fines DM, Babirye JP, McCann LH, et al. IFN-gamma-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1alpha. PLoS Pathog. 2022;18(7): e1010721. https://doi.org/10.1371/journal.ppat.1010721.
留言 (0)